Pharma Industry Review

AbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage

Google DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.

Next-level T Cell Staining with imusyn’s Dyemer & myDyemer Reagents An imusyn Flyer Groundbreaking T Cell staining reagents designed for

Infrareal Holding plans to take over Takeda’s pharma and biotech site specialising in gene and cell therapies in Orth, Lower

AstraZeneca’s Truqap (capivasertib) has achieved a significant milestone in the treatment of prostate cancer. Results from the CAPItello-281 Phase III

The leading global biotechnology company advancing protein-based vaccines, Novavax, announced that the European Commission has granted Marketing Authorisation for the

This high-throughput microsomal binding assay, requires only 20 min to measure the affinity of drugs to human microsomal membranes and